Narrows FY24 revenue view to $1.750B-$1.850B from $1.650B-$1.850B. Consensus is for FY24 EPS $1.42 and for revenue $1.76B. Sees FY24 Adjusted EBITDA $165M-$185M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTH:
- Astrana Health price target raised to $60 from $48 at Stifel
- Astrana Health price target raised to $60 from $50 at BTIG
- Astrana Health Announces Major Acquisitions and Earnout Agreement
- Astrana Health to acquire Collaborative Health Systems, no terms disclosed
- Astrana Health and Elation Health partner in infrastructure solution